Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

156.35
Delayed Data
As of 4:00pm ET
 -2.64 / -1.66%
Today’s Change
130.09
Today|||52-Week Range
181.81
-3.68%
Year-to-Date

Today’s Trading

Previous close158.99
Today’s open158.37
Day’s range156.00 - 158.46
Volume2,862,931
Average volume (3 months)3,665,646
Market cap$119.2B
Dividend yield2.56%
Data as of 4:00pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+6.76%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+6.49%
P/E ratio17.3
Price/Sales5.83
Price/Book4.27

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-1.83-2.06%
BIIBBiogen+0.02+0.01%
BXLTBaxalta Inc+0.14+0.33%
BAXBaxter International...-0.32-0.72%
Data as of 4:02pm ET, 05/03/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$2.74
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhavan Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts

Partner Offers

Search for Jobs